Defining the canonical form of T-cell-mediated rejection in human kidney transplants

K. S. Famulski, G. Einecke, B. Sis, M. Mengel, L. G. Hidalgo, B. Kaplan, P. F. Halloran

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Banff defines T-cell-mediated rejection (TCMR) using nonspecific lesions and arbitrary cutoffs, with no external gold standard. We reexamined features of TCMR using exclusively molecular definition independent of histopathology. The definition was derived from mouse kidney transplants with fully developed TCMR, and is based on high expression of transcripts reflecting IFNG effects and alternative macrophage activation. In 234 human kidney transplant biopsies for cause phenotyped by microarrays, we identified 26 biopsies meeting these criteria. After excluding three biopsies with unrelated diseases, all 23 biopsies had typical Banff lesions of TCMR (inflammation, tubulitis), with v lesions in 10/23. Banff histopathology diagnosed 18 as TCMR, 1 as mixed and 4 as borderline. Despite marked changes in transcriptome indicating tissue injury and dedifferentiation, all kidneys with molecularly defined TCMR, even with v lesions or late rejection, demonstrated excellent recovery of function at 6 months with no graft loss (mean follow-up 2.5 years). Thus TCMR defined exclusively by molecules manifests TCMR-related lesions and function impairment, but good recovery and survival, even with late rejection or arteritis. This combination of pathologic, clinical and molecular features constitutes the typical or canonical T-cell-mediated rejection.

Original languageEnglish (US)
Pages (from-to)810-820
Number of pages11
JournalAmerican Journal of Transplantation
Volume10
Issue number4
DOIs
StatePublished - Apr 2010
Externally publishedYes

Fingerprint

T-Lymphocytes
Transplants
Kidney
Biopsy
Arteritis
Macrophage Activation
Recovery of Function
Transcriptome
Inflammation
Survival
Wounds and Injuries

Keywords

  • Antibody
  • Banff classification
  • Macrophages
  • Microarrays
  • Rejection

ASJC Scopus subject areas

  • Transplantation
  • Immunology and Allergy
  • Pharmacology (medical)

Cite this

Famulski, K. S., Einecke, G., Sis, B., Mengel, M., Hidalgo, L. G., Kaplan, B., & Halloran, P. F. (2010). Defining the canonical form of T-cell-mediated rejection in human kidney transplants. American Journal of Transplantation, 10(4), 810-820. https://doi.org/10.1111/j.1600-6143.2009.03007.x

Defining the canonical form of T-cell-mediated rejection in human kidney transplants. / Famulski, K. S.; Einecke, G.; Sis, B.; Mengel, M.; Hidalgo, L. G.; Kaplan, B.; Halloran, P. F.

In: American Journal of Transplantation, Vol. 10, No. 4, 04.2010, p. 810-820.

Research output: Contribution to journalArticle

Famulski, KS, Einecke, G, Sis, B, Mengel, M, Hidalgo, LG, Kaplan, B & Halloran, PF 2010, 'Defining the canonical form of T-cell-mediated rejection in human kidney transplants', American Journal of Transplantation, vol. 10, no. 4, pp. 810-820. https://doi.org/10.1111/j.1600-6143.2009.03007.x
Famulski, K. S. ; Einecke, G. ; Sis, B. ; Mengel, M. ; Hidalgo, L. G. ; Kaplan, B. ; Halloran, P. F. / Defining the canonical form of T-cell-mediated rejection in human kidney transplants. In: American Journal of Transplantation. 2010 ; Vol. 10, No. 4. pp. 810-820.
@article{c199cd46710a47e0a863f764562a7e4b,
title = "Defining the canonical form of T-cell-mediated rejection in human kidney transplants",
abstract = "Banff defines T-cell-mediated rejection (TCMR) using nonspecific lesions and arbitrary cutoffs, with no external gold standard. We reexamined features of TCMR using exclusively molecular definition independent of histopathology. The definition was derived from mouse kidney transplants with fully developed TCMR, and is based on high expression of transcripts reflecting IFNG effects and alternative macrophage activation. In 234 human kidney transplant biopsies for cause phenotyped by microarrays, we identified 26 biopsies meeting these criteria. After excluding three biopsies with unrelated diseases, all 23 biopsies had typical Banff lesions of TCMR (inflammation, tubulitis), with v lesions in 10/23. Banff histopathology diagnosed 18 as TCMR, 1 as mixed and 4 as borderline. Despite marked changes in transcriptome indicating tissue injury and dedifferentiation, all kidneys with molecularly defined TCMR, even with v lesions or late rejection, demonstrated excellent recovery of function at 6 months with no graft loss (mean follow-up 2.5 years). Thus TCMR defined exclusively by molecules manifests TCMR-related lesions and function impairment, but good recovery and survival, even with late rejection or arteritis. This combination of pathologic, clinical and molecular features constitutes the typical or canonical T-cell-mediated rejection.",
keywords = "Antibody, Banff classification, Macrophages, Microarrays, Rejection",
author = "Famulski, {K. S.} and G. Einecke and B. Sis and M. Mengel and Hidalgo, {L. G.} and B. Kaplan and Halloran, {P. F.}",
year = "2010",
month = "4",
doi = "10.1111/j.1600-6143.2009.03007.x",
language = "English (US)",
volume = "10",
pages = "810--820",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Defining the canonical form of T-cell-mediated rejection in human kidney transplants

AU - Famulski, K. S.

AU - Einecke, G.

AU - Sis, B.

AU - Mengel, M.

AU - Hidalgo, L. G.

AU - Kaplan, B.

AU - Halloran, P. F.

PY - 2010/4

Y1 - 2010/4

N2 - Banff defines T-cell-mediated rejection (TCMR) using nonspecific lesions and arbitrary cutoffs, with no external gold standard. We reexamined features of TCMR using exclusively molecular definition independent of histopathology. The definition was derived from mouse kidney transplants with fully developed TCMR, and is based on high expression of transcripts reflecting IFNG effects and alternative macrophage activation. In 234 human kidney transplant biopsies for cause phenotyped by microarrays, we identified 26 biopsies meeting these criteria. After excluding three biopsies with unrelated diseases, all 23 biopsies had typical Banff lesions of TCMR (inflammation, tubulitis), with v lesions in 10/23. Banff histopathology diagnosed 18 as TCMR, 1 as mixed and 4 as borderline. Despite marked changes in transcriptome indicating tissue injury and dedifferentiation, all kidneys with molecularly defined TCMR, even with v lesions or late rejection, demonstrated excellent recovery of function at 6 months with no graft loss (mean follow-up 2.5 years). Thus TCMR defined exclusively by molecules manifests TCMR-related lesions and function impairment, but good recovery and survival, even with late rejection or arteritis. This combination of pathologic, clinical and molecular features constitutes the typical or canonical T-cell-mediated rejection.

AB - Banff defines T-cell-mediated rejection (TCMR) using nonspecific lesions and arbitrary cutoffs, with no external gold standard. We reexamined features of TCMR using exclusively molecular definition independent of histopathology. The definition was derived from mouse kidney transplants with fully developed TCMR, and is based on high expression of transcripts reflecting IFNG effects and alternative macrophage activation. In 234 human kidney transplant biopsies for cause phenotyped by microarrays, we identified 26 biopsies meeting these criteria. After excluding three biopsies with unrelated diseases, all 23 biopsies had typical Banff lesions of TCMR (inflammation, tubulitis), with v lesions in 10/23. Banff histopathology diagnosed 18 as TCMR, 1 as mixed and 4 as borderline. Despite marked changes in transcriptome indicating tissue injury and dedifferentiation, all kidneys with molecularly defined TCMR, even with v lesions or late rejection, demonstrated excellent recovery of function at 6 months with no graft loss (mean follow-up 2.5 years). Thus TCMR defined exclusively by molecules manifests TCMR-related lesions and function impairment, but good recovery and survival, even with late rejection or arteritis. This combination of pathologic, clinical and molecular features constitutes the typical or canonical T-cell-mediated rejection.

KW - Antibody

KW - Banff classification

KW - Macrophages

KW - Microarrays

KW - Rejection

UR - http://www.scopus.com/inward/record.url?scp=77949794956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949794956&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2009.03007.x

DO - 10.1111/j.1600-6143.2009.03007.x

M3 - Article

C2 - 20132168

AN - SCOPUS:77949794956

VL - 10

SP - 810

EP - 820

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 4

ER -